239P - Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Updated safety results of a phase II trial (AGMT MBC-6)
- Resource Type
- Abstract
- Source
- In
Annals of Oncology 1 October 2016 27 Supplement 6:vi73-vi73 - Subject
- Language
- ISSN
- 0923-7534